Financial reports
10-K
2023 FY
Annual report
22 Apr 24
NT 10-K
Notice of late annual filing
1 Apr 24
10-Q
2023 Q3
Quarterly report
2 Nov 23
10-Q
2023 Q2
Quarterly report
3 Aug 23
10-Q
2023 Q1
Quarterly report
11 May 23
ARS
2022 FY
Annual report to shareholders
27 Apr 23
10-K
2022 FY
Annual report
23 Mar 23
10-Q
2022 Q3
Quarterly report
3 Nov 22
10-Q
2022 Q2
Quarterly report
9 Aug 22
10-Q
2022 Q1
Quarterly report
11 May 22
Current reports
8-K
Entry into a Material Definitive Agreement
24 Apr 24
8-K
Entry into a Material Definitive Agreement
24 Apr 24
8-K
Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
22 Apr 24
8-K
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
16 Apr 24
8-K
Submission of Matters to a Vote of Security Holders
5 Apr 24
8-K
Other Events
9 Feb 24
8-K
Other Events
22 Dec 23
8-K
Other Events
17 Nov 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
16 Nov 23
8-K
Cidara Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results
2 Nov 23
Registration and prospectus
S-8
Registration of securities for employees
22 Apr 24
S-8
Registration of securities for employees
23 Mar 23
424B5
Prospectus supplement for primary offering
6 Mar 23
424B5
Prospectus supplement for primary offering
6 Mar 23
424B5
Prospectus supplement for primary offering
2 Mar 23
424B5
Prospectus supplement for primary offering
2 Mar 23
S-8
Registration of securities for employees
7 Mar 22
S-3
Shelf registration
10 Nov 21
424B5
Prospectus supplement for primary offering
8 Oct 21
424B5
Prospectus supplement for primary offering
8 Oct 21
Proxies
DEF 14A
Definitive proxy
4 Mar 24
PRE 14A
Preliminary proxy
23 Feb 24
DEFA14A
Additional proxy soliciting materials
27 Apr 23
DEF 14A
Definitive proxy
27 Apr 23
DEFA14A
Additional proxy soliciting materials
29 Nov 22
DEF 14A
Definitive proxy
10 Nov 22
PRE 14A
Preliminary proxy
31 Oct 22
DEFA14A
Additional proxy soliciting materials
29 Apr 22
DEF 14A
Definitive proxy
29 Apr 22
DEFA14A
Additional proxy soliciting materials
28 Apr 21
Other
UPLOAD
Letter from SEC
24 Jul 23
CORRESP
Correspondence with SEC
7 Jul 23
UPLOAD
Letter from SEC
26 Jun 23
CORRESP
Correspondence with SEC
31 May 23
UPLOAD
Letter from SEC
28 Apr 23
EFFECT
Notice of effectiveness
23 Nov 21
CORRESP
Correspondence with SEC
18 Nov 21
UPLOAD
Letter from SEC
17 Nov 21
EFFECT
Notice of effectiveness
17 Jun 20
CORRESP
Correspondence with SEC
12 Jun 20